Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · IEX Real-Time Price · USD
145.61
+1.83 (1.27%)
At close: Jul 19, 2024, 4:00 PM
145.60
-0.01 (-0.01%)
Pre-market: Jul 22, 2024, 5:31 AM EDT
Sarepta Therapeutics Market Cap
Sarepta Therapeutics has a market cap or net worth of $13.76 billion as of July 22, 2024. Its market cap has increased by 34.33% in one year.
Market Cap
13.76B
Enterprise Value
13.75B
1-Year Change
34.33%
Ranking
Category
Stock Price
$145.61
Market Cap Chart
Since December 1, 1998, Sarepta Therapeutics's market cap has increased from $58.40M to $13.76B, an increase of 23,467.83%. That is a compound annual growth rate of 23.73%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 13.76B | 52.58% |
Dec 29, 2023 | 9.02B | -20.70% |
Dec 30, 2022 | 11.37B | 45.06% |
Dec 31, 2021 | 7.84B | -41.72% |
Dec 31, 2020 | 13.45B | 39.87% |
Dec 31, 2019 | 9.62B | 31.90% |
Dec 31, 2018 | 7.29B | 102.79% |
Dec 29, 2017 | 3.60B | 140.16% |
Dec 30, 2016 | 1.50B | -14.27% |
Dec 31, 2015 | 1.75B | 192.17% |
Dec 31, 2014 | 597.80M | -21.92% |
Dec 31, 2013 | 765.60M | 16.58% |
Dec 31, 2012 | 656.70M | 549.55% |
Dec 30, 2011 | 101.10M | -57.54% |
Dec 31, 2010 | 238.10M | 47.70% |
Dec 31, 2009 | 161.20M | 244.44% |
Dec 31, 2008 | 46.80M | -38.26% |
Dec 31, 2007 | 75.80M | -54.99% |
Dec 29, 2006 | 168.40M | 10.50% |
Dec 30, 2005 | 152.40M | 79.51% |
Dec 31, 2004 | 84.90M | -33.15% |
Dec 31, 2003 | 127.00M | -3.93% |
Dec 31, 2002 | 132.20M | -47.73% |
Dec 31, 2001 | 252.90M | 148.18% |
Dec 29, 2000 | 101.90M | 40.36% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BioMarin Pharmaceutical | 15.97B |
Incyte | 14.81B |
Neurocrine Biosciences | 14.66B |
United Therapeutics | 14.60B |
Viatris | 14.10B |
Insulet | 13.66B |
Revvity | 13.34B |
Medpace Holdings | 13.05B |